09 July 2021

Plenary session 2 report: Incontinence care challenges and management in elderly patients

Drug-drug interactions (DDIs), expert insights on mesh usage, and the patients’ perspective were some of the topics covered today during

09 July 2021

Urine biomarkers for treatment response

Considerable unmet biomarker potential exists in the treatment of bladder cancer By Dr. Patrick Hensley (Houston, US) & Dr. Ashish M. Kamat (Houston,

09 July 2021

Antimicrobial resistance: How to deal with the pandemic

By Dr. José Medina-Polo (Madrid, ES), Associate Member of the ESIU This article reflects the highlights of the lecture Dr. José Medina-Polo

09 July 2021

Insightful and eye-opening presentations at first-ever EAU Patient Day

Today was the birth of the very first EAU Patient Day at the Annual EAU Congress. On the second day

08 July 2021

Welcome to the 36th Annual EAU Congress

08 July 2021

Urology beyond Europe: Different approaches, same goal

The mission of the European Association of Urology (EAU) is to raise the level of urological care throughout Europe and

08 July 2021

Report: Semi-live surgery session also weighs up educational value and future potential

“Technology development never ends!” was the catch-all title for the nearly eight-hour flagship semi-live surgical session at EAU21, and it

08 July 2021

Incontinence mesh removal surgery in women

By Dr. Marie-Aimée Perrouin-Verbe (Nantes, FR), Department of Urology, Nantes Academic Hospital & Prof. Hashim Hashim (Bristol, GB), Bristol Urological Institute, Southmead Hospital This

08 July 2021

Using pharmacotherapy for OAB: What drug interactions to be aware of

By Prof. Martin C. Michel (Mainz, DE), Department of Pharmacology, Johannes Gutenberg University This article reflects the highlights of the lecture Prof.

08 July 2021

EAU21 opens with full-day semi-live surgery and Urology Beyond Europe sessions

EAU Secretary General Prof. Chris Chapple welcomed delegates to the 36th Annual EAU Congress, EAU21. Speaking from a studio in

07 July 2021

The PIONEER Big Data platform: How does it apply to prostate cancer?

By Dr. Susan Evans Axelsson (Malmö, SE), Clinical Coordinator PIONEER This article reflects the highlights of the lecture Dr. Susan Evans Axelsson

06 July 2021

RPLND for chemo-resistant disease: Examining different options for different patients

By Prof. Axel Heidenreich (Cologne, DE), Department of Urology, University Hospital Cologne This article reflects the highlights of the lecture Prof.

05 July 2021

Immunotherapy for metastatic urothelial cancer

New agents are expected to significantly improve overall prognosis By Dr. Ursula Vogl (Bellinzona, CH), medical oncologist at Ospedale San Giovanni